Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Arrowhead Pharmaceuticals (ARWR) Net Income (2016 - 2025)

Arrowhead Pharmaceuticals' Net Income history spans 16 years, with the latest figure at $28.2 million for Q4 2025.

For Q4 2025, Net Income rose 116.12% year-over-year to $28.2 million; the TTM value through Dec 2025 reached $233.6 million, up 135.96%, while the annual FY2025 figure was $30.1 million, 104.94% up from the prior year.
Net Income reached $28.2 million in Q4 2025 per ARWR's latest filing, up from $16.1 million in the prior quarter.
In the past five years, Net Income ranged from a high of $367.9 million in Q1 2025 to a low of -$178.7 million in Q2 2025.
Average Net Income over 5 years is -$52.9 million, with a median of -$67.7 million recorded in 2021.
Peak YoY movement for Net Income: tumbled 366.37% in 2024, then surged 389.67% in 2025.
A 5-year view of Net Income shows it stood at -$62.9 million in 2021, then skyrocketed by 33.53% to -$41.8 million in 2022, then crashed by 223.91% to -$135.4 million in 2023, then dropped by 29.43% to -$175.2 million in 2024, then soared by 116.12% to $28.2 million in 2025.
Per Business Quant, the three most recent readings for ARWR's Net Income are $28.2 million (Q4 2025), $16.1 million (Q3 2025), and -$178.7 million (Q2 2025).